{"600345":{"#nid":"600345","#data":{"type":"news","title":"Mannino Wins National Award","body":[{"value":"\u003Cp\u003ERobert Mannino, a Ph.D. student in the Wallace H. Coulter Department of Biomedical Engineering (BME) at the Georgia Institute of Technology and Emory University, took top honors in competition for the 2017 Student Technology Prize for Primary Healthcare, held in Boston and hosted by Massachusetts General Hospital Ambulatory Practice of the Future.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe annual national competition encourages graduate and undergraduate engineering students to direct their creative skills toward the needs of primary care \u0026ndash; innovations that have a substantial potential to improve the delivery of care, whether they be technologies, instrumentation, devices, or systems.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe technologies of particular interest improve access to medical care, leverage the skills of caregivers, automate routine tasks, increase workflow efficiency, support patients with chronic disease, increase compliance with protocols, reduce error, or augment the physician-patient relationship.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EMannino, who works in the lab of Wilbur Lam, associate professor of BME and a researcher in the Petit Institute for Bioengineering and Bioscience, won the $100,000 top prize. It will support \u003Ca href=\u0022http:\/\/www.news.gatech.edu\/features\/perfect-patient\u0022\u003Ehis research\u003C\/a\u003E, based on his Ph.D. dissertation, which he\u0026rsquo;ll defend this year. He\u0026rsquo;s developing a smartphone app to non-invasively diagnose anemia.\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EIt\u0026rsquo;s research that hits close to home for Mannino, who was born with a rare genetic blood disorder, thalassemia major, which causes anemia and requires him to receive a blood transfusion every month. Basically, says Lam, \u0026ldquo;his Ph.D. is centered on developing new diagnostics for his own disease.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EHe\u0026rsquo;s already completed an initial clinical assessment of the system, which uses smartphone photos of the patient\u0026rsquo;s fingernails for diagnosis.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"BME graduate student takes top Student Technology Prize"}],"field_summary":[{"value":"\u003Cp\u003EBME graduate student takes top Student Technology Prize\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"BME graduate student takes top Student Technology Prize"}],"uid":"28153","created_gmt":"2018-01-03 17:58:32","changed_gmt":"2018-11-29 19:11:03","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2018-01-03T00:00:00-05:00","iso_date":"2018-01-03T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"600344":{"id":"600344","type":"image","title":"Robert Mannino in lab","body":null,"created":"1515001946","gmt_created":"2018-01-03 17:52:26","changed":"1515001946","gmt_changed":"2018-01-03 17:52:26","alt":"","file":{"fid":"228868","name":"RobertMannino.jpg","image_path":"\/sites\/default\/files\/images\/RobertMannino.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/RobertMannino.jpg","mime":"image\/jpeg","size":1298762,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/RobertMannino.jpg?itok=BrhHVaC6"}}},"media_ids":["600344"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"126571","name":"go-PetitInstitute"},{"id":"173016","name":"go-apdc"},{"id":"172669","name":"go-icrc-news"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:jerry.grillo@ibb.gatech.edu\u0022\u003EJerry Grillo\u003C\/a\u003E\u003Cbr \/\u003E\r\nCommunications Officer II\u003Cbr \/\u003E\r\nParker H. Petit Institute for\u003Cbr \/\u003E\r\nBioengineering and Bioscience\u003C\/p\u003E\r\n","format":"limited_html"}],"email":["Jerry.grillo@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"606743":{"#nid":"606743","#data":{"type":"news","title":"Improving Gene Therapy","body":[{"value":"\u003Cp\u003ELast year, commercial medical history was made when the Food and Drug Administration (FDA) approved the first gene therapy treatment, Kymriah, in the U.S., opening the door to a new world of treatment for devastating diseases. As reports from clinical trials of tisagenlecleucel (marketed as Kymriah) became public \u0026ndash; that it used a patient\u0026rsquo;s own T-cells to actually kill cancer \u0026ndash; the news media called it a miracle cure.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EOf course, it took decades of research, a lot of trial and error at the molecular level. The concept, transplanting normal or healthy genes into cells in place of missing or defective genes in order to treat diseases and disorders, has been under development since the Reagan administration.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;The idea of gene therapy\u0026rsquo;s been around since I was a kid,\u0026rdquo; says Wilbur Lam, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and the Georgia Institute of Technology and researcher in the Petit Institute for Bioengineering and Bioscience at Georgia Tech. \u0026ldquo;In the 1990s, gene therapy trials mostly failed and often caused deadly side effects like cancer. But the entire field has moved forward, and the field of gene therapy has now learned how to actually cure people.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EAs it turns out, miracles are not only complex and elusive, they\u0026rsquo;re also expensive, to the point of being infeasible for large scale clinical translation. But with support from a new R01 grant from the National Institutes of Health (NIH), Lam\u0026rsquo;s lab is working to make gene therapies more efficient, and more economically accessible.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EKymriah, for example, has a price tag of $475,000 (or about $20,000 less than the value of Lam\u0026rsquo;s new four-year NIH grant).\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;That price tag is largely a result of the difficulty and cost associated with viral vector manufacturing, which is, unfortunately, the key to these novel therapies,\u0026rdquo; says Reginald Tran, a postdoctoral researcher in Lam\u0026rsquo;s lab who is using microfluidic technology that he developed to incorporate basic mass transfer and fluid mechanics principles to increase gene therapy efficiency.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EIn gene therapy modified viruses often are used as vectors, or vehicles, to carry the good-guy genes into a human cell. It\u0026rsquo;s been proven to work, but it\u0026rsquo;s not a very efficient process, according to Lam. For one thing, \u0026ldquo;it takes about a billion cells to treat an adult for something like sickle cell disease,\u0026rdquo; he says.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EAlso, Lam notes that these engineered viral vectors have a half-life, \u0026ldquo;and they\u0026rsquo;ll deactivate if they don\u0026rsquo;t find their target cell in time. They will die. Excess virus is given to cells to ensure that enough cells get genetically modified, but this results in added costs and significant waste of the precious key reagent. \u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ETran, who earned his Ph.D. in the Lam lab, says he was amazed to learn about the capabilities of microfluidics, and how leveraging the differences in physics at the micro scale could unlock new possibilities for diagnostics and therapeutics.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;This project was really ideal for me since I could combine my backgrounds in mechanical engineering and microfluidics toward gene and cell therapy,\u0026rdquo; Tran adds. \u0026ldquo;I quickly found that microfluidics were the perfect platform to efficiently bring cells and viral vectors together to maximize gene transfer.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EPerforming the critical gene\u0026nbsp;transfer step in microfluidics dramatically reduces processing time and resources (up to five times less viral vector can be used). While many researchers continue to work on developing more potent genes or increasing viral vector manufacturing potential, the Lam group is focused on using less virus.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;At a time when virus shortages present a huge bottleneck in gene and cell therapy commercialization, we believe that our technology can help make these treatments more accessible and affordable for patients,\u0026rdquo; Tran says. \u0026ldquo;I feel extremely lucky to work on a problem that has the potential to make a meaningful impact on what could very well be the next frontier in modern medicine.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Lam lab using new NIH grant to make groundbreaking treatments more efficient and accessible"}],"field_summary":[{"value":"\u003Cp\u003ELam lab using new NIH grant to make groundbreaking treatments more efficient and accessible\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"Lam lab using new NIH grant to make groundbreaking treatments more efficient and accessible"}],"uid":"28153","created_gmt":"2018-06-04 18:30:31","changed_gmt":"2018-06-04 20:43:52","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2018-06-04T00:00:00-04:00","iso_date":"2018-06-04T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"606742":{"id":"606742","type":"image","title":"Wilbur Lam","body":null,"created":"1528136697","gmt_created":"2018-06-04 18:24:57","changed":"1528136697","gmt_changed":"2018-06-04 18:24:57","alt":"","file":{"fid":"231411","name":"WilburLam2.jpg","image_path":"\/sites\/default\/files\/images\/WilburLam2.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/WilburLam2.jpg","mime":"image\/jpeg","size":2405916,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/WilburLam2.jpg?itok=b1IljRxj"}},"606741":{"id":"606741","type":"image","title":"Reggie Tran","body":null,"created":"1528136659","gmt_created":"2018-06-04 18:24:19","changed":"1528136659","gmt_changed":"2018-06-04 18:24:19","alt":"","file":{"fid":"231410","name":"R.Tran_Headshot.jpg","image_path":"\/sites\/default\/files\/images\/R.Tran_Headshot.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/R.Tran_Headshot.jpg","mime":"image\/jpeg","size":279126,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/R.Tran_Headshot.jpg?itok=t6tZ0Q9k"}}},"media_ids":["606742","606741"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"126571","name":"go-PetitInstitute"},{"id":"1612","name":"BME"},{"id":"14566","name":"Gene Therapy"},{"id":"175498","name":"CMaT"},{"id":"171346","name":"go-rem"},{"id":"173016","name":"go-apdc"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:jerry.grillo@ibb.gatech.edu\u0022\u003EJerry Grillo\u003C\/a\u003E\u003Cbr \/\u003E\r\nCommunications Officer II\u003Cbr \/\u003E\r\nParker H. Petit Institute for\u003Cbr \/\u003E\r\nBioengineering and Bioscience\u003C\/p\u003E\r\n","format":"limited_html"}],"email":["Jerry.grillo@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"606003":{"#nid":"606003","#data":{"type":"news","title":"Mayo Clinic Taps Tech Capstone Team","body":[{"value":"\u003Cp\u003ELarry Huang has made a career of turning good ideas into tangible results.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ESince graduating from the Georgia Institute of Technology with a degree in industrial management in 1973, he\u0026rsquo;s been an entrepreneur, helping to create billion-dollar companies. He\u0026rsquo;s been a race car driver, competing in the NASCAR Rolex Grand-Am Sports Car series. A former member of the Georgia Tech Foundation Board of Trustees, he\u0026rsquo;s been a philanthropist, endowing the Lawrence P. Huang Chair in Engineering Entrepreneurship (currently held by David Ku, researcher in the Petit Institute for Bioengineering and Bioscience at Georgia Tech.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ERecently, Huang has taken on a new role: matchmaker. Through a series of events that he encapsulates as \u0026ldquo;a really serendipitous situation,\u0026rdquo; Huang linked Mayo Clinic in Jacksonville, Florida, with a team of interdisciplinary Capstone Design students at Georgia Tech, forging a new collaboration in the evolving relationship between Mayo and Tech\u0026rsquo;s bio-community.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;It\u0026rsquo;s the classic win-win scenario,\u0026rdquo; says Huang, who is a patient at Mayo, where his reputation preceded him \u0026ndash; Huang\u0026rsquo;s generosity had previously nourished Mayo Clinic Ventures, and he\u0026rsquo;s been trying to jumpstart technology infrastructure in Jacksonville since moving to the area 18 years ago, \u0026ldquo;with limited success,\u0026rdquo; he says.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EBut the southern stars are aligning as Mayo Clinic is in the midst of a massive $330 million expansion on its Florida campus, \u0026ldquo;to enhance research and innovation,\u0026rdquo; according to Gianrico Farrugia (physician and CEO of Mayo Clinic\u0026rsquo;s Florida campus) and Tushar Patel (physician scientist and Mayo\u0026rsquo;s Dean for Research in Florida), in a newspaper editorial they co-wrote last year.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Mayo has a tremendous amount of intellectual property, and they\u0026rsquo;re building an incubator to commercialize that, they want to develop a start-up hub for the Southeast. But it became obvious to me right away that there is a missing piece,\u0026rdquo; says Huang, who met with Charles Bruce, M.D., the Mayo physician leading the effort. \u0026ldquo;You can have all the intellectual property, the clinicians, the technical and scientific knowledge, but in order to build a product or a service, you need engineers and a business plan.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Ch4\u003E\u003Cstrong\u003EGoing to the Source\u003C\/strong\u003E\u003C\/h4\u003E\r\n\r\n\u003Cp\u003ESince Huang had graduated, a thriving bioengineering and biomedical engineering community had emerged at Georgia Tech, so he knew exactly where to turn. Huang brought Mayo\u0026rsquo;s planners together with leadership at Georgia Tech, including Petit Institute Executive Director Bob Guldberg, Scheller College of Business Dean Maryam Alavi, and James Rains, who directs the Capstone program for the Wallace H. Coulter Department of Biomedical Engineering (BME) at Georgia Tech and Emory University.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;So we started looking for Capstone teams with a real entrepreneurial interest, and a lot of people applied,\u0026rdquo; says Rains. Ultimately, they selected an interdisciplinary team of five biomedical and mechanical engineering students that called itself \u0026ndash; of course \u0026ndash; Cinco de Mayo.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe team has three BME students: Dev Mandavia, Marci Medford, Cassidy Wang; and two from the Woodruff School of Mechanical Engineering: Alex Bills and Lucas Muller. If there was an ace in the hole, it was probably Mandavia, who has valuable experience when it comes to competitive entrepreneurial endeavors. He helped lead the BME team (CauteryGuard) that won last year\u0026rsquo;s Georgia Tech and Atlantic Coast Conference InVenture Prizes.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ECinco de Mayo actually got a head-start on its spring semester Capstone project, making trips to Jacksonville before the semester to meet with clinicians. According to Medford, they conducted about 200 interviews with personnel at Mayo, as well as the Piedmont and Grady health systems in Atlanta.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;We decided to focus on epidurals, because we realized there are so many complications related to the procedure, and we felt that we could make an impact,\u0026rdquo; says Medford.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe team considered about 10 different problems supplied by Mayo clinicians, asking itself, \u0026ldquo;what is going to have the biggest impact and be the easiest to implement, that last part being pretty important,\u0026rdquo; says Mandavia. \u0026ldquo;Having gone through the process of developing a medical device last year with CauteryGuard, I knew that you can create the best thing in the world, but if nobody\u0026rsquo;s interested in using it, you can\u0026rsquo;t really impact change.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Ch4\u003E\u003Cstrong\u003ESharp Focus\u003C\/strong\u003E\u003C\/h4\u003E\r\n\r\n\u003Cp\u003EThey focused on the delivery of neuraxial anesthesia (like an epidural), used extensively in the obstetric setting to alleviate pain during childbirth. With an epidural, a needle is inserted into the back to deliver drugs into the space around the spinal cord. Currently, these procedures are conducted without imaging or precise feedback that could alert the physician where and how deep to insert the needle.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;The clinical issue is getting guidance or feedback when gaining access to the epidural and intrathecal space,\u0026rdquo; says cardiologist\/cardiac electrophysiologist K.L. Venkatachalam, M.D., one of the clinicians that worked with the Capstone team. \u0026ldquo;This is presently done with a special needle and most procedures are done simply based on anatomic considerations, with very little feedback about optimal position and angle of the needle.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ESo, physicians are virtually blind, depending on tactile feedback and \u0026ldquo;loss of resistance\u0026rdquo; upon entry into the epidural space. Proficiency is gained and maintained only through continuous practice. Meanwhile, multiple attempts are usually made to place the needle, increasing pain and the risk of complications.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;This is a standard practice in labor and delivery,\u0026rdquo; Mandavia says. \u0026ldquo;These procedures are done millions of times a year. You can\u0026rsquo;t use fluoroscopy or X-rays, because you expose the baby to harmful radiation.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe current version of the \u0026lsquo;NeuraLine\u0026rsquo; device they developed uses bioelectric impedance analysis and\/or force sensing, allowing physicians to identify entry into specific anatomical spaces. Other modalities may also be explored. The Cinco de Mayo team will have a better sense of its next steps following a May 4\u003Csup\u003Eth\u003C\/sup\u003E meeting at Mayo, an opportunity to show and tell for an audience of clinicians and experts.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Ch4\u003E\u003Cstrong\u003EPublic Debut\u003C\/strong\u003E\u003C\/h4\u003E\r\n\r\n\u003Cp\u003EFirst, they unveiled the product at the spring semester Capstone Design Expo (April 24), a competition won by a \u003Ca href=\u0022https:\/\/www.bme.gatech.edu\/bme\/bme-team-takes-home-top-capstone-prize\u0022\u003EBME team called Kit Cath\u003C\/a\u003E. Then they spent the next week and a half preparing for the meeting at Mayo, which Mandavia described as, \u0026ldquo;a culmination of everything we\u0026rsquo;ve done, the steps we took to get here, the prototyping, the iterations, the user interviews, everything that went into it, and also a look into the future. We really think this is something that could impact a lot of people.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ETheir device aims to improve clinical confidence, minimize complication rates, and eliminate the steep learning curve of the current practice. Accounting for all neuroaxial procedures in the U.S., the team estimates the total addressable market to be $5 billion. The team plans to devote itself to further development of the device this summer.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EAnd going forward, professor of the practice James Rains envisions an ongoing relationship between the Mayo Clinic and BME Capstone teams, \u0026ldquo;in which we connect these outstanding young engineers with leading physicians to solve clinical problems.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EMayo already is collaborating with Georgia Tech\u0026rsquo;s bio-community in a meaningful way as an organizing partner and gold sponsor of the annual \u003Ca href=\u0022http:\/\/www.rh.gatech.edu\/news\/604377\/historic-regenerative-medicine-workshop-wraps\u0022\u003ERegenerative Medicine Workshop\u003C\/a\u003E, launched by Tech more than two decades ago and brought together each year by a team that also includes the University of Wisconsin, University of Pittsburgh, and the Regenerative Engineering and Medicine Center (a partnership of Emory, Georgia Tech, and the University of Georgia).\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThis kind of cross pollination between disciplines, between engineering students and clinicians, \u0026ldquo;is crucial in coming up with solutions to this problem,\u0026rdquo; says Venkatachalam. \u0026ldquo;This was a great example of working together to come up with a viable, inexpensive solution.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe students and Mayo clinicians kept in touch throughout the process with weekly video conferences, looking at various approaches, as well as several face-to-face meetings, which allowed the physicians to show the engineering students the clinical arena and the challenges health care providers face during the procedure.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;I thought the students were bright, enthusiastic, and motivated to succeed,\u0026rdquo; Venkatachalam says. \u0026ldquo;I was pleased to see them step back to get a good understanding of the big picture, including the clinical need and the potential market.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EFor Larry Huang, the value of partnering with Capstone students is something he became well acquainted with last year, when he tapped a team of mechanical engineering (ME) students to redesign the intake system for the air box on one of his race cars.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EBut this latest experience with the interdisciplinary team of BME and ME students gets closer to the core of what has driven him for more than 40 years.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;I\u0026rsquo;ve been interested in the commercialization of technology for a long time,\u0026rdquo; Huang says. \u0026ldquo;It\u0026rsquo;s because I\u0026rsquo;ve always thought that this is a way to really make people\u0026rsquo;s lives better while also creating value.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022https:\/\/youtu.be\/-wY2xkIqv70\u0022\u003E\u003Cstrong\u003EView Team Neuraline\u0026#39;s presentation to the Mayo Clinic here.\u003C\/strong\u003E\u003C\/a\u003E\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"BME and ME students collaborate on novel device to improve epidural procedures"}],"field_summary":[{"value":"\u003Cp\u003EBME and ME students collaborate on novel device to improve epidural procedures\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"BME and ME students collaborate on novel device to improve epidural procedures"}],"uid":"28153","created_gmt":"2018-05-09 15:15:19","changed_gmt":"2018-05-11 14:29:03","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2018-05-09T00:00:00-04:00","iso_date":"2018-05-09T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"605999":{"id":"605999","type":"image","title":"Neuraline Team","body":null,"created":"1525878058","gmt_created":"2018-05-09 15:00:58","changed":"1525878098","gmt_changed":"2018-05-09 15:01:38","alt":"","file":{"fid":"231113","name":"Neuraline team.jpg","image_path":"\/sites\/default\/files\/images\/Neuraline%20team.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Neuraline%20team.jpg","mime":"image\/jpeg","size":511682,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Neuraline%20team.jpg?itok=zdNShTus"}},"606000":{"id":"606000","type":"image","title":"Medford Neuraline","body":null,"created":"1525878166","gmt_created":"2018-05-09 15:02:46","changed":"1525878166","gmt_changed":"2018-05-09 15:02:46","alt":"","file":{"fid":"231114","name":"Marci Neuraline.jpg","image_path":"\/sites\/default\/files\/images\/Marci%20Neuraline.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Marci%20Neuraline.jpg","mime":"image\/jpeg","size":3787782,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Marci%20Neuraline.jpg?itok=BLN28aBD"}},"606001":{"id":"606001","type":"image","title":"Cassidy Neuraline","body":null,"created":"1525878274","gmt_created":"2018-05-09 15:04:34","changed":"1525878274","gmt_changed":"2018-05-09 15:04:34","alt":"","file":{"fid":"231115","name":"Cassidy Neuraline.jpg","image_path":"\/sites\/default\/files\/images\/Cassidy%20Neuraline.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Cassidy%20Neuraline.jpg","mime":"image\/jpeg","size":1014530,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Cassidy%20Neuraline.jpg?itok=9KleE30f"}},"606002":{"id":"606002","type":"image","title":"Dev, Buzz, Marci","body":null,"created":"1525878338","gmt_created":"2018-05-09 15:05:38","changed":"1525878338","gmt_changed":"2018-05-09 15:05:38","alt":"","file":{"fid":"231116","name":"Dev, Buzz, and Marci.jpg","image_path":"\/sites\/default\/files\/images\/Dev%2C%20Buzz%2C%20and%20Marci.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Dev%2C%20Buzz%2C%20and%20Marci.jpg","mime":"image\/jpeg","size":1909115,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Dev%2C%20Buzz%2C%20and%20Marci.jpg?itok=6trd6e8C"}}},"media_ids":["605999","606000","606001","606002"],"groups":[{"id":"1254","name":"Wallace H. Coulter Dept. of Biomedical Engineering"}],"categories":[],"keywords":[{"id":"1612","name":"BME"},{"id":"126571","name":"go-PetitInstitute"},{"id":"173016","name":"go-apdc"},{"id":"5298","name":"mayo clinic"},{"id":"12652","name":"capstone"},{"id":"177919","name":"epidural"},{"id":"7780","name":"anesthesia"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:jerry.grillo@ibb.gatech.edu\u0022\u003EJerry Grillo\u003C\/a\u003E\u003Cbr \/\u003E\r\nCommunications Officer II\u003Cbr \/\u003E\r\nParker H. Petit Institute for\u003Cbr \/\u003E\r\nBioengineering and Bioscience\u003C\/p\u003E\r\n","format":"limited_html"}],"email":["Jerry.grillo@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"600846":{"#nid":"600846","#data":{"type":"news","title":"Building a Better Brace","body":[{"value":"\u003Cp\u003EJohn Harvey is an active 8-year-old with spina bifida, who gets around pretty well right now with the help of braces, crutches, and a wheelchair. But he\u0026rsquo;s a growing boy and his parents have their eyes on the future, and they wonder about the tools he\u0026rsquo;ll use to help him along his evolving path from Point A to Point B.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;We\u0026rsquo;re concerned with the challenges he\u0026rsquo;ll face as he gets older and taller,\u0026rdquo; says his mom, Stephanie Harvey of Atlanta. \u0026ldquo;The last thing we want to do is inhibit him.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;He needs functional tools that grow with him,\u0026rdquo; adds his dad, Stu.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EWith that in mind, last summer the Harveys contacted the \u003Ca href=\u0022http:\/\/bmecapstone.gatech.edu\/\u0022\u003EBME Capstone\u003C\/a\u003E program at the Wallace H. Coulter Department of Biomedical Engineering (BME) at the Georgia Institute of Technology and Emory University.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EEvery semester through the Capstone program, BME seniors experience all aspects of product development, with an emphasis on medical devices, working towards the goal of producing functional prototypes to address the needs of a wide range of users. For the Fall 2017 semester, one of those users was John Harvey. Turns out, the Harveys already had a connection with Tech.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;At one point, all four of our babysitters were Georgia Tech seniors or graduates, and one of them knew all about the BME Capstone program,\u0026rdquo; says Stu.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ESo they contacted program director James Rains, then submitted their project proposal and soon made a new group of talented friends in BME seniors Zinka Bartolek, Renee Copeland, Samantha Houser, Davira \u0026ldquo;Tia\u0026rdquo; Widianto, and Brice Williams.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Ch4\u003E\u003Cstrong\u003EPerfect Fit\u003C\/strong\u003E\u003C\/h4\u003E\r\n\r\n\u003Cp\u003EThe students had \u0026ldquo;a bunch of projects to consider,\u0026rdquo; says Houser, but they quickly discovered that their goals and skill sets converged perfectly with the Harveys\u0026rsquo; interests.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;John\u0026rsquo;s family was frustrated with some of his bracing solutions. They weren\u0026rsquo;t providing him with the mobility they\u0026rsquo;d like to see,\u0026rdquo; says Houser who, with her teammates, graduated following the fall semester. \u0026ldquo;This was a great fit for us.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EWilliams, who like most of his teammates is planning on medical school, adds, \u0026ldquo;one of the main reasons this project appealed to me is, I\u0026rsquo;d like to go into pediatrics. This gave me a glimpse into that world, and the challenges in pediatric medicine.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ESo, with the coordination of Children\u0026rsquo;s Healthcare of Atlanta, the BME seniors and Harveys joined forces. The team spent about two months doing interviews with the Harveys, with John\u0026rsquo;s physical therapists, his orthotists, other professionals and patients they met through the Spina Bifida Association of Georgia, which sponsored the annual Walk n\u0026rsquo; Roll for Spina Bifida on the Georgia Tech campus in October.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe timing of that event was fortuitous. Copeland \u0026ndash; a former Petit Institute Undergraduate Research Scholar \u0026ndash; was researching spina bifida and happened to read about the 12\u003Csup\u003Eth\u003C\/sup\u003E annual Walk n\u0026rsquo; Roll. \u0026ldquo;And then we had two weeks to get everything ready, but it was really lucky for us, because we were able to get a lot of user interviews done that day,\u0026rdquo; Copeland says.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;By that point, we\u0026rsquo;d already sketched out almost 100 design iterations,\u0026rdquo; says Widianto. \u0026ldquo;We let the families that were there offer feedback, write down what they liked, what they didn\u0026rsquo;t. We had a lot of sticky notes.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThey gathered all of that data and gave it to the Harveys, who consulted with John\u0026rsquo;s therapists and orthotists, to pick a final design.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Ch4\u003E\u003Cstrong\u003EBrace for Awesomeness\u003C\/strong\u003E\u003C\/h4\u003E\r\n\r\n\u003Cp\u003EPediatric medical devices, like the knee-ankle-foot orthosics (KAFOs) John uses, can do wonders, but they are limited in few ways: They don\u0026rsquo;t grow with a child\u0026rsquo;s maturing body, and they don\u0026rsquo;t promote proper balance or natural ambulation, which can lead to bone growth issues down the road.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ESo the team\u0026rsquo;s mission statement was, \u0026ldquo;improve ambulation of pediatric spina bifida patients through a novel orthotic solution that allows knee mobility during walking while supporting the user\u0026rsquo;s weight, without deforming.\u0026rdquo; With that goal in mind, young John gave the team a name: Brace for Awesomeness.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EWhen John wears his standard device for ambulation, it has to be locked in a fully extended position for structural support, but this results in an unnatural gait. The team\u0026rsquo;s final prototype, WalkSense, is a pressure sensor calibrated device that controls the locking state of the knee based on the walking cycle. WalkSense sends a signal from the heel of the KAFO up to the knee to a locking device.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EBrace for Awareness unveiled its prototype at the fall edition of the \u003Ca href=\u0022http:\/\/www.me.gatech.edu\/featured_2017_Capstone_winners\u0022\u003ECapstone Design Expo\u003C\/a\u003E in December, when 136 teams put their work on display, (including Liv\u0026rsquo;R Little, which won in the \u003Ca href=\u0022https:\/\/www.bme.gatech.edu\/bme\/laparoscopic-liver-maneuvering-device-wins-bme-category-capstone-expo\u0022\u003EBME category\u003C\/a\u003E at the expo).\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;We had a chance to show off what we\u0026rsquo;d done and where we\u0026rsquo;d been,\u0026rdquo; says Houser. Over the course of several months, the team became like members of the Harveys\u0026rsquo; extended family, going to dinner at the house, going to doctor\u0026rsquo;s appointments, physical therapy.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;They truly took time to get to know and understand John and our family \u0026ndash; they really went above and beyond,\u0026rdquo; Stephanie says.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Ch4\u003E\u003Cstrong\u003EBig Night, Big Hopes\u003C\/strong\u003E\u003C\/h4\u003E\r\n\r\n\u003Cp\u003EIt all came together at the Expo. The team used videos, a large poster, and the prototype to tell the story of their Capstone journey.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;The highlight of the night was showing the Harveys the device, and seeing the excitement in every single member of the family, including all three of the children,\u0026rdquo; says Copeland, the former Petit Scholar who\u0026rsquo;d been named Ms. Georgia Tech just weeks before the Expo. \u0026ldquo;Every family member played a part in the process, and it was exciting to see their reactions, and imagine what the final version of this device might be, and what it would mean to John.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ETheir product, the WalkSense, was only a prototype and not ready for regular patient use yet, \u0026ldquo;but it\u0026rsquo;s definitely a prototype that can be leveraged into the next phase,\u0026rdquo; Stu believes.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EIt\u0026rsquo;s a work in progress, and the family has been discussing the future possibilities with John\u0026rsquo;s regular care team of physicians, therapists, and orthotists. The family is thinking long-range, with visions that extend beyond their own experience.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;When I think about my son\u0026rsquo;s life, the surgeries he\u0026rsquo;s had, and later, the medical devices, someone had to pave the way,\u0026rdquo; Stu says. \u0026ldquo;Our goal is to see if something could be developed to help John, but also to help the children like him 20 years from now.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"BME Capstone team addresses mobility challenges for young spina bifida patient"}],"field_summary":[{"value":"\u003Cp\u003EBME Capstone team addresses mobility challenges for young spina bifida patient\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"BME Capstone team addresses mobility challenges for young spina bifida patient"}],"uid":"28153","created_gmt":"2018-01-16 16:17:06","changed_gmt":"2018-01-16 16:17:06","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2018-01-16T00:00:00-05:00","iso_date":"2018-01-16T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"600845":{"id":"600845","type":"image","title":"Brace for Awesomeness","body":null,"created":"1516118744","gmt_created":"2018-01-16 16:05:44","changed":"1516118744","gmt_changed":"2018-01-16 16:05:44","alt":"","file":{"fid":"229041","name":"Capstone_Pic.jpg","image_path":"\/sites\/default\/files\/images\/Capstone_Pic.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Capstone_Pic.jpg","mime":"image\/jpeg","size":4606114,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Capstone_Pic.jpg?itok=ujjXaNW4"}}},"media_ids":["600845"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"126571","name":"go-PetitInstitute"},{"id":"173016","name":"go-apdc"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:jerry.grillo@ibb.gatech.edu\u0022\u003EJerry Grillo\u003C\/a\u003E\u003Cbr \/\u003E\r\nCommunications Officer II\u003Cbr \/\u003E\r\nParker H. Petit Institute for\u003Cbr \/\u003E\r\nBioengineering and Bioscience\u003C\/p\u003E\r\n","format":"limited_html"}],"email":["Jerry.grillo@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"596400":{"#nid":"596400","#data":{"type":"news","title":"Georgia Clinical \u0026 Translational Science Alliance Receives $51 Million NIH Grant","body":[{"value":"\u003Cp\u003EAfter a decade of research collaboration, the Atlanta Clinical \u0026amp; Translational Science Institute (ACTSI) will welcome a new partner and change its name, reflecting a new statewide focus. The University of Georgia will officially become the fourth academic partner, and ACTSI will now be known as the \u003Ca href=\u0022http:\/\/www.GeorgiaCTSA.org\u0022\u003EGeorgia Clinical \u0026amp; Translational Science Alliance\u003C\/a\u003E (Georgia CTSA).\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThis alliance is celebrating 10 years of research advancement by expanding across the state through a five-year, $51 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). The Emory University-led Georgia CTSA will focus on transforming the quality and value of clinical research and translating research results into better outcomes for patients.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe Georgia CTSA unites the strengths of its academic partners: \u003Ca href=\u0022http:\/\/www.emory.edu\u0022\u003EEmory University\u003C\/a\u003E, \u003Ca href=\u0022http:\/\/www.msm.edu\/\u0022\u003EMorehouse School of Medicine\u003C\/a\u003E, the Georgia Institute of Technology, and the \u003Ca href=\u0022http:\/\/www.uga.edu\u0022\u003EUniversity of Georgia\u003C\/a\u003E. Emory is a national leader in health care and biomedical research as well as an outstanding leader in clinical and translational research training and education. Morehouse School of Medicine is a nationally recognized historically black institution that brings ethnic diversity to biomedical research, addresses health disparities through successful community engagement research, and serves as a pipeline for training minority researchers. Georgia Tech is a national leader in biomedical engineering, bioinformatics\u0026nbsp; and the application of innovative systems engineering to health care solutions. The University of Georgia has a proven track record in outstanding basic and translational research and, as the state\u0026rsquo;s land grant institution, offers a robust statewide network that enhances community outreach, service and research.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Continuing such an alliance and involving these leading state institutions is extremely important and in line with Georgia\u0026rsquo;s goals for the promotion of clinical and translational research, innovation and development,\u0026rdquo; said Georgia Governor Nathan Deal. \u0026ldquo;Having an active Clinical \u0026amp; Translational Science awardee in Georgia has brought our citizens cutting edge cures and the latest in clinical and translational research.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EGeorgia CTSA is one of 64 Clinical and Translational Science Awards (CTSA) at major academic medical centers across the country, funded by the National Institutes of Health\u0026rsquo;s \u003Ca href=\u0022https:\/\/ncats.nih.gov\/\u0022\u003ENational Center for Advancing Translational Science\u003C\/a\u003E, and it is the only CTSA in Georgia. The award will fund cores focused on improving quality, efficiency and collaboration of the research process; provide consultative support and new tools in informatics and biostatistics; pilot funding for new research projects, training and workforce development, while integrating special populations and focusing on participant interactions, and creating local centers tackling clinical trial inefficiencies.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe Georgia CTSA welcomes contact principal investigator (PI) at Emory, W. Robert Taylor, M.D., Ph.D., and a new multi-PI leadership structure:\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/medicine.emory.edu\/cardiology\/faculty-directory\/taylor-w-robert.html\u0022\u003E\u003Cstrong\u003EW. Robert Taylor, MD, PhD\u003C\/strong\u003E\u003C\/a\u003E\u003Cbr \/\u003E\r\nContact Principal Investigator, Georgia CTSA\u003Cbr \/\u003E\r\nInterim Chair, Department of Medicine\u003Cbr \/\u003E\r\nDirector, Division of Cardiology\u003Cbr \/\u003E\r\nMarcus Chair in Vascular Medicine\u003Cbr \/\u003E\r\nProfessor of Medicine and Biomedical Engineering\u003Cbr \/\u003E\r\nEmory University School of Medicine\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msm.edu\/about_us\/FacultyDirectory\/Medicine\/ElizabethOfili\/index.php\u0022\u003E\u003Cstrong\u003EElizabeth O. Ofili, MD, MPH\u003C\/strong\u003E\u003C\/a\u003E\u003Cbr \/\u003E\r\nPrincipal Investigator, Morehouse School of Medicine, Georgia CTSA\u0026nbsp;\u003Cbr \/\u003E\r\nProfessor of Medicine, Cardiology\u003Cbr \/\u003E\r\nSenior Associate Dean of Clinical and Translational Research\u003Cbr \/\u003E\r\nDirector, Clinical Research Center\u0026nbsp;\u003Cbr \/\u003E\r\nMorehouse School of Medicine\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.me.gatech.edu\/faculty\/garcia\u0022\u003E\u003Cstrong\u003EAndr\u0026eacute;s J. Garc\u0026iacute;a, PhD\u003C\/strong\u003E\u003C\/a\u003E\u003Cbr \/\u003E\r\nPrincipal Investigator, Georgia Institute of Technology, Georgia CTSA\u0026nbsp;\u003Cbr \/\u003E\r\nRae S. and Frank H. Neely Endowed Chair and Regents\u0026#39; Professor, Woodruff School of Mechanical Engineering and Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\r\nDirector, Interdisciplinary Bioengineering Graduate Program\u003Cbr \/\u003E\r\nGeorgia Institute of Technology\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/cap.rx.uga.edu\/index.php\/people\/faculty\/phillips\/\u0022\u003E\u003Cstrong\u003EBradley G. Phillips, PharmD, BCPS, FCCP\u003C\/strong\u003E\u003C\/a\u003E\u003Cbr \/\u003E\r\nPrincipal Investigator, University of Georgia, Georgia CTSA\u003Cbr \/\u003E\r\nMillikan-Reeve Professor and Head, Clinical \u0026amp; Administrative Pharmacy, College of Pharmacy\u0026nbsp;\u003Cbr \/\u003E\r\nDirector, Clinical and Translational Research Unit (CTRU), Office of Research\u003Cbr \/\u003E\r\nUniversity of Georgia\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/medicine.emory.edu\/infectious-diseases\/faculty-directory\/blumberg-henry-michael.html\u0022\u003E\u003Cstrong\u003EHenry M. Blumberg, MD\u003C\/strong\u003E\u003C\/a\u003E\u003Cbr \/\u003E\r\nPrincipal Investigator, KL2 and TL1, Georgia CTSA\u003Cbr \/\u003E\r\nProfessor of Medicine and Epidemiology, Division of Infectious Diseases\u003Cbr \/\u003E\r\nEmory University School of Medicine\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026quot;The Georgia CTSA creates a unique opportunity for synergy among historic partners in health care, education, and cutting edge research, and has emerged as an innovative and integrated environment where clinical and translational researchers can flourish,\u0026quot; said Taylor. \u0026quot;The Georgia CTSA is a catalyst and incubator for clinical and translational research across the state, with impacts throughout the Southeast and nation.\u0026quot;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe Georgia CTSA has improved health care and research for Georgia citizens through collaboration with the Grady Health System, Children\u0026rsquo;s Healthcare of Atlanta, Atlanta VA Medical Center, Georgia Research Alliance, Georgia Bio, and multiple community medical groups throughout the state.\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026quot;Georgia CTSA continues established, strong clinical and research partnerships by leveraging the infrastructure support of the NIH-funded Research Centers at Minority Institutions (RCMI) at Morehouse School of Medicine. We will continue to implement innovative patient centered and participatory care delivery models, toward the elimination of health disparities,\u0026quot; said Ofili.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Georgia CTSA\u0026rsquo;s innovative support of discovery and collaborative partnerships help\u0026nbsp;to rapidly translate scientific discoveries and new technology, which positively impacts patient care in Georgia. This is an exciting story for the state,\u0026rdquo; said Garcia. \u0026ldquo;The new alliance is improving health care and clinical research for the citizens of Georgia and continues to create synergies that foster and accelerate new and emerging technologies and discoveries.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;The addition of the University of Georgia provides the Georgia CTSA a statewide footprint to connect with every county in the state to address health and wellness needs, particularly in rural and underserved populations; opportunities for continued excellence in research by strengthening existing and expanding new research collaborations; and the ability to enrich interprofessional education to include students and trainees from pharmacy and other disciplines so that they can learn how to work together as a team to discover new approaches and treatments that improve health and patient care,\u0026rdquo; said Phillips.\u0026nbsp;\u0026ldquo;As a new member of the Georgia CTSA, faculty and students across our campus will have unique support and infrastructure that builds upon current capabilities and increases our trajectory in fostering clinical and translational science in the state and beyond.\u0026rdquo;\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Cem\u003EWritten by\u0026nbsp;Georgia Clinical \u0026amp; Translational Science Alliance\u003C\/em\u003E.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EFor more information, please visit \u003Ca href=\u0022http:\/\/www.GeorgiaCTSA.org\u0022\u003Ewww.GeorgiaCTSA.org\u003C\/a\u003E\u0026nbsp;\u0026nbsp;\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EAfter a decade of research collaboration, the Atlanta Clinical \u0026amp; Translational Science Institute (ACTSI) will welcome a new partner and change its name, reflecting a new statewide focus. The University of Georgia will officially become the fourth academic partner, and ACTSI will now be known as the Georgia Clinical \u0026amp; Translational Science Alliance (Georgia CTSA). This alliance is celebrating 10 years of research advancement by expanding across the state through a five-year, $51 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH).\u0026nbsp;\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"The Georgia Clinical \u0026 Translational Science Alliance has received a $51 million NIH grant"}],"uid":"27303","created_gmt":"2017-09-25 02:07:04","changed_gmt":"2017-09-28 12:55:02","author":"John Toon","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2017-09-25T00:00:00-04:00","iso_date":"2017-09-25T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"596398":{"id":"596398","type":"image","title":"Andres Garcia and diabetes research","body":null,"created":"1506304217","gmt_created":"2017-09-25 01:50:17","changed":"1506304641","gmt_changed":"2017-09-25 01:57:21","alt":"Andres Garcia and Jessica Weaver studying pancreatic cells.","file":{"fid":"227295","name":"DSC_5002.jpg","image_path":"\/sites\/default\/files\/images\/DSC_5002.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/DSC_5002.jpg","mime":"image\/jpeg","size":437238,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/DSC_5002.jpg?itok=SxyfGqhj"}},"596399":{"id":"596399","type":"image","title":"Andres Garcia and diabetes research2","body":null,"created":"1506304606","gmt_created":"2017-09-25 01:56:46","changed":"1506304606","gmt_changed":"2017-09-25 01:56:46","alt":"Andres Garcia and Jessica Weaver studying pancreatic cells.","file":{"fid":"227296","name":"DSC_5002.jpg","image_path":"\/sites\/default\/files\/images\/DSC_5002_0.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/DSC_5002_0.jpg","mime":"image\/jpeg","size":437238,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/DSC_5002_0.jpg?itok=Cj5PpJh_"}},"596446":{"id":"596446","type":"image","title":"W. Robert Taylor","body":null,"created":"1506363789","gmt_created":"2017-09-25 18:23:09","changed":"1506363789","gmt_changed":"2017-09-25 18:23:09","alt":"W. Robert Taylor","file":{"fid":"227320","name":"roberttaylor.jpg","image_path":"\/sites\/default\/files\/images\/roberttaylor.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/roberttaylor.jpg","mime":"image\/jpeg","size":1780128,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/roberttaylor.jpg?itok=LibzEVrq"}}},"media_ids":["596398","596399","596446"],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"135","name":"Research"},{"id":"138","name":"Biotechnology, Health, Bioengineering, Genetics"},{"id":"146","name":"Life Sciences and Biology"}],"keywords":[{"id":"8030","name":"CTSA"},{"id":"175654","name":"Georgia CTSA"},{"id":"5649","name":"ACTSI"},{"id":"175655","name":"Georgia Clinical \u0026 Translational Science Alliance"},{"id":"171346","name":"go-rem"},{"id":"173016","name":"go-apdc"},{"id":"175342","name":"go-medicalrobotics"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[{"id":"71891","name":"Health and Medicine"}],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EJohn Toon\u003C\/p\u003E\r\n\r\n\u003Cp\u003EResearch News\u003C\/p\u003E\r\n\r\n\u003Cp\u003E(404) 894-6986\u003C\/p\u003E\r\n","format":"limited_html"}],"email":["jtoon@gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"588926":{"#nid":"588926","#data":{"type":"news","title":"Self-Repaired Eyesight","body":[{"value":"\u003Cp\u003EResearchers with the Regenerative Engineering and Medicine research center (REM) have developed a new way to identify and sort stem cells that may one day allow clinicians to restore vision to people with damaged corneas using the patient\u0026rsquo;s own eye tissue. They published their findings in\u0026nbsp;\u003Cem\u003EBiophysical Journal\u003C\/em\u003E.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe cornea is a transparent layer of tissue covering the front of the eye, and its health is maintained by a group of cells called limbal stem cells. But when these cells are damaged by trauma or disease, the cornea loses its ability to self-repair.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Damage to the limbus, which is where the clear part of the eye meets the white part of the eye, can cause the cornea to break down very rapidly,\u0026rdquo; said James Lauderdale, an associate professor of cellular biology in the University of Georgia\u0026#39;s (UGA) Franklin College of Arts and Sciences and paper co-author. \u0026ldquo;The only way to repair the cornea right now is do a limbal cell transplant from donated tissue.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EIn their study, researchers used a new type of highly sensitive atomic force microscopy, or AFM, to analyze eye cell cultures. Created by\u0026nbsp;\u003Ca href=\u0022http:\/\/www.me.gatech.edu\/faculty\/sulchek\u0022\u003ETodd Sulchek\u003C\/a\u003E, a researcher at the Petit Institute for Bioengineering and Bioscience\u0026nbsp;and an associate professor in the\u0026nbsp;\u003Ca href=\u0022http:\/\/www.me.gatech.edu\/\u0022\u003EGeorge W. Woodruff School of Mechanical Engineering\u003C\/a\u003E\u0026nbsp;at Georgia Tech, the technique allowed researchers to probe and exert force on individual cells to learn more about the cell\u0026rsquo;s overall health and its ability to turn into different types of mature cells.\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ERead the complete story \u003Ca href=\u0022http:\/\/www.rh.gatech.edu\/news\/588600\/stem-cell-treatment-may-restore-vision-patients-damaged-corneas\u0022\u003Ehere.\u003C\/a\u003E\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Stem cell treatment may restore vision to patients with damaged corneas"}],"field_summary":[{"value":"\u003Cp\u003EStem cell treatment may restore vision to patients with damaged corneas\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"Stem cell treatment may restore vision to patients with damaged corneas"}],"uid":"28153","created_gmt":"2017-03-17 13:11:49","changed_gmt":"2017-05-15 17:25:05","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2017-03-17T00:00:00-04:00","iso_date":"2017-03-17T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"588598":{"id":"588598","type":"image","title":"Todd Sulchek and microfluidic device","body":null,"created":"1489179074","gmt_created":"2017-03-10 20:51:14","changed":"1489179074","gmt_changed":"2017-03-10 20:51:14","alt":"Todd Sulchek and microfluidic device","file":{"fid":"224307","name":"14C10039-P1-004.jpg","image_path":"\/sites\/default\/files\/images\/14C10039-P1-004.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/14C10039-P1-004.jpg","mime":"image\/jpeg","size":343279,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/14C10039-P1-004.jpg?itok=_CrlEpIf"}}},"media_ids":["588598"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"171346","name":"go-rem"},{"id":"173016","name":"go-apdc"},{"id":"126221","name":"go-immuno"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}},"590386":{"#nid":"590386","#data":{"type":"news","title":"Reducing Worry and Waste","body":[{"value":"\u003Cp\u003EA project funded by the Atlantic Pediatric Device Consortium (APDC, which is headquartered at the Petit Institute for Bioengineering and Bioscience) will help relieve the stress and anxiety (and cost) that parents face in the wake of discovering their child has a heart murmur.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EConsider the scenario: During a routine exam, a pediatrician hears a heart murmur and refers the child to a cardiologist and an appointment is scheduled for a few days (or weeks) later. The parents are terrified, but put on their brave faces.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EWhen the appointment finally arrives, the cardiologist listens and soon diagnoses a Still\u0026rsquo;s murmur, which is completely harmless. The parents finally exhale, and a potentially life-changing problem simply evaporates.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThis scenario plays out more than a million times each year. Pediatricians don\u0026rsquo;t want to take a chance the murmur might be serious, and as a result, parents and older children face needless anxiety and the healthcare system wastes $650 million annually on unnecessary referrals.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe device being developed by AusculTech Dx is designed to be used by pediatricians to quickly diagnose Still\u0026rsquo;s murmurs, ultimately saving money and stress for patients and the healthcare system. Read the whole story \u003Ca href=\u0022http:\/\/medcitynews.com\/2017\/03\/medical-device-startup-wants-make-easier-detect-harmless-heart-murmur\/?rf=1\u0022\u003Ehere.\u003C\/a\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Cstrong\u003ELINKS:\u003C\/strong\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/atlanticpediatricdeviceconsortium.org\/\u0022\u003EAPDC\u003C\/a\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.auscultechdx.com\/\u0022\u003EAusculTech Dx\u003C\/a\u003E\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Startup supported by Atlantic Pediatric Device Consortium making it easier to detect harmless heart murmurs"}],"field_summary":[{"value":"\u003Cp\u003EStartup supported by Atlantic Pediatric Device Consortium making it easier to detect harmless heart murmurs\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"Startup supported by Atlantic Pediatric Device Consortium making it easier to detect harmless heart murmurs"}],"uid":"28153","created_gmt":"2017-04-14 13:59:53","changed_gmt":"2017-04-14 13:59:53","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2017-04-14T00:00:00-04:00","iso_date":"2017-04-14T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"590383":{"id":"590383","type":"image","title":"prototype","body":null,"created":"1492175930","gmt_created":"2017-04-14 13:18:50","changed":"1492175930","gmt_changed":"2017-04-14 13:18:50","alt":"","file":{"fid":"224931","name":"Prototype.png","image_path":"\/sites\/default\/files\/images\/Prototype.png","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Prototype.png","mime":"image\/png","size":705089,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Prototype.png?itok=uswnSmlx"}}},"media_ids":["590383"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"173016","name":"go-apdc"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}},"585113":{"#nid":"585113","#data":{"type":"news","title":"Patiently Growing","body":[{"value":"\u003Cp\u003ERobert Matheny, a cardiothoracic surgeon, is giving last-minute instructions to another surgeon who is about to operate on a baby 2,000 miles away in a neon city.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;How old is the child? Thirteen months? Yeah, yeah, I think that would be fine,\u0026rdquo; Matheny says, then pauses a few seconds before continuing in the secret code of his profession. \u0026ldquo;OK, line up the seam at the seven o\u0026rsquo;clock position on the annulus, down to the septal papillary muscles, and make a good u-stitch and then put an extra bit through it so that you get three bites \u0026ndash; even four if you feel like it\u0026rsquo;s necessary \u0026ndash; through each anchor point, and it\u0026rsquo;s pretty forgiving.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EHe pauses another second and adds, \u0026ldquo;That should work great.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003EIt does work great. The patient, known as \u0026ldquo;Baby Las Vegas,\u0026rdquo; is now at home and doing well after receiving a tricuspid valve replacement with a novel device created by CorMatrix, the company Matheny co-founded. Based in Roswell, Ga., CorMatrix has twice received a critical financial boost through the Atlantic Pediatric Device Consortium (APDC), headquartered at the Petit Institute for Bioengineering and Bioscience at the Georgia Institute of Technology.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EIn 2012, CorMatrix first received APDC funding for its prosthetic trileaflet valve. In September 2016, the company received a fresh round of APDC funding for its regenerating tubular mitral valve device for babies. Both projects utilize CorMatrix\u0026rsquo;s patented extracellular matrix (ECM).\u003C\/p\u003E\r\n\r\n\u003Cp\u003EECM is a naturally occurring bioscaffold that surrounds cells in most tissues. It allows for cell adhesion, differentiation, division, and migration. CorMatrix\u0026rsquo;s ECM material acts as a scaffold into which the patient\u0026rsquo;s own cells migrate and integrate, stimulating wound healing mechanisms, which mature to form a strong, permanent tissue repair.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EAPDC leadership was particularly interested in how the company\u0026rsquo;s proposed products address one of the major issues related to pediatric medical devices: young people grow.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Children are growing as they get older, and that can be a major stumbling block,\u0026rdquo; notes David Ku, who is APDC\u0026rsquo;s executive director as well as the Lawrence P. Huang Chair Professor of Engineering Entrepreneurship, a Regents\u0026rsquo; Professor of Mechanical Engineering, and Petit Institute researcher.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Let\u0026rsquo;s say that a child at four needs a heart valve,\u0026rdquo; Ku says. \u0026ldquo;By the time he\u0026rsquo;s 12, that valve will probably need to double in size, which would mean another surgery. What\u0026rsquo;s interesting about this company is, they\u0026rsquo;ve addressed this major problem because their tissue grows with the child.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ECorMatrix is produced in manner that retains natural ECM molecules, including growth factors, proteins, and cytokines, which play important roles in host tissue repair and remodeling. So far, CorMatrix devices have been used as a biologic scaffold in a variety of surgical applications, especially cardiac and vascular repairs. The idea is to give surgeons the ability to create a growing native anatomy, serving as a better alternative to synthetic or cross-linked materials.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EThe company was founded as CorMatrix Cardiovascular Inc., in 2001. It has deep roots at Georgia Tech, but was built on technology that came out of Purdue University, where Matheny had been doing cardiovascular research. He moved to Atlanta in 1999 to start a lab at the facility now known as T3 Labs (T3, for Translational Testing and Training), next door to the Georgia Tech campus.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EMatheny, who had been balancing his roles as researcher and physician, ultimately gave up his clinical practice as CorMatrix demanded more of his time. \u0026nbsp;Along the way, he\u0026rsquo;s partnered with Georgia Tech researchers to develop the CorMatrix technology and move it forward into other applications.\u003C\/p\u003E\r\n\r\n\u003Cp\u003EMost importantly, he partnered with Anna Fallon, who earned her Ph.D. while working in the lab of Petit Institute researcher Ajit Yoganathan, who is a professor and associate chair for translational research in the Wallace H. Coulter Department of Biomedical Engineering. Fallon (who recently left CorMatrix to become director of research for MiMedx) was co-principal investigator with Matheny for CorMatrix\u0026rsquo;s first APDC-funded project.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Anna had ECM experience. She wanted to work on valves, and she really was the product development person for us,\u0026rdquo; Matheny says of his former colleague. \u0026ldquo;And she\u0026rsquo;s the one who told me what was available through APDC.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003ECorMatrix received its first clearance from the Food and Drug Administration (FDA) in 2005. For a couple of years, before moving into its current facility in Roswell in January 2013, the company was actually headquartered in the basement of the Petit Institute building.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ESo far, CorMatrix has been used at nearly 1,000 hospitals, and been implanted in more than 145,000 cardiac and vascular procedures, including one in a 13-month baby in Las Vegas. Matheny likes his company\u0026rsquo;s odds going forward.\u003C\/p\u003E\r\n\r\n\u003Cp\u003ETo date, all of the company\u0026rsquo;s funding has come from APDC or individuals, like Bernie Marcus. The philanthropist and Home Depot co-founder is particularly interested in mitral and tricuspid valves. Heart valves are taking up a lot of the company\u0026rsquo;s time and interest these days, but Matheny sees the opportunity for plenty of other applications for this biological tool that he has harnessed, a tool that can grow with the patient.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026ldquo;Now that we\u0026rsquo;re learning the recipe, there really isn\u0026rsquo;t a tissue that\u0026rsquo;s off limits,\u0026rdquo; he says. \u0026ldquo;It (ECM) has moved into the clinical field, and I think it\u0026rsquo;s just a matter of time before it replaces most synthetics.\u0026rdquo;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003E\u003Ca href=\u0022http:\/\/cormatrix.com\/\u0022\u003ECorMatrix\u003C\/a\u003E\u003C\/strong\u003E\u003C\/em\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/atlanticpediatricdeviceconsortium.org\/\u0022\u003E\u003Cem\u003E\u003Cstrong\u003EAPDC\u003C\/strong\u003E\u003C\/em\u003E\u003C\/a\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Cstrong\u003ECONTACT:\u003C\/strong\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Ca href=\u0022mailto:jerry.grillo@ibb.gatech.edu\u0022\u003EJerry Grillo\u003C\/a\u003E\u003Cbr \/\u003E\r\nCommunications Officer II\u003Cbr \/\u003E\r\nParker H. Petit Institute for\u003Cbr \/\u003E\r\nBioengineering and Bioscience\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"APDC-supported CorMatrix, develops devices that can grow with the patient"}],"field_summary":[{"value":"\u003Cp\u003EAPDC-supported CorMatrix, develops devices that can grow with the patient\u003C\/p\u003E\r\n","format":"limited_html"}],"field_summary_sentence":[{"value":"APDC-supported CorMatrix, develops devices that can grow with the patient"}],"uid":"28153","created_gmt":"2016-12-15 18:13:06","changed_gmt":"2016-12-15 20:11:20","author":"Jerry Grillo","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2016-12-15T00:00:00-05:00","iso_date":"2016-12-15T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"585109":{"id":"585109","type":"image","title":"Robert Matheny and patient","body":null,"created":"1481824402","gmt_created":"2016-12-15 17:53:22","changed":"1481824402","gmt_changed":"2016-12-15 17:53:22","alt":"","file":{"fid":"223071","name":"Honduran boy CorMatrix patient.jpg","image_path":"\/sites\/default\/files\/images\/Honduran%20boy%20CorMatrix%20patient.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Honduran%20boy%20CorMatrix%20patient.jpg","mime":"image\/jpeg","size":1046707,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Honduran%20boy%20CorMatrix%20patient.jpg?itok=EvYqjpfp"}},"585110":{"id":"585110","type":"image","title":"Tricuspid valve","body":null,"created":"1481824485","gmt_created":"2016-12-15 17:54:45","changed":"1481824485","gmt_changed":"2016-12-15 17:54:45","alt":"","file":{"fid":"223072","name":"Tricuspid Valve Animal Model.png","image_path":"\/sites\/default\/files\/images\/Tricuspid%20Valve%20Animal%20Model.png","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Tricuspid%20Valve%20Animal%20Model.png","mime":"image\/png","size":171922,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Tricuspid%20Valve%20Animal%20Model.png?itok=I2fTOwPy"}},"585108":{"id":"585108","type":"image","title":"Anna Fallon","body":null,"created":"1481824330","gmt_created":"2016-12-15 17:52:10","changed":"1481824330","gmt_changed":"2016-12-15 17:52:10","alt":"","file":{"fid":"223070","name":"AnnaF.jpg","image_path":"\/sites\/default\/files\/images\/AnnaF.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/AnnaF.jpg","mime":"image\/jpeg","size":1682412,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/AnnaF.jpg?itok=vQ_AsHrC"}},"585111":{"id":"585111","type":"image","title":"CorMatrix ECM","body":null,"created":"1481824559","gmt_created":"2016-12-15 17:55:59","changed":"1481824559","gmt_changed":"2016-12-15 17:55:59","alt":"","file":{"fid":"223073","name":"Hydrated Cormatrix ECM.png","image_path":"\/sites\/default\/files\/images\/Hydrated%20Cormatrix%20ECM.png","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/images\/Hydrated%20Cormatrix%20ECM.png","mime":"image\/png","size":949607,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Hydrated%20Cormatrix%20ECM.png?itok=VnEJtSvm"}}},"media_ids":["585109","585110","585108","585111"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"},{"id":"1254","name":"Wallace H. Coulter Dept. of Biomedical Engineering"}],"categories":[],"keywords":[{"id":"172532","name":"Atlantic Pediatric Device Consortium"},{"id":"14864","name":"apdc"},{"id":"173016","name":"go-apdc"},{"id":"147071","name":"go_apdc"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:jerry.grillo@ibb.gatech.edu\u0022\u003EJerry Grillo\u003C\/a\u003E\u003Cbr \/\u003E\r\nCommunications Officer II\u003Cbr \/\u003E\r\nParker H. Petit Institute for\u003Cbr \/\u003E\r\nBioengineering and Bioscience\u003C\/p\u003E\r\n","format":"limited_html"}],"email":["Jerry.grillo@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}